Retour
Fourchette du Jour
22,00 €
22,00 €
Fourchette 52 Semaines
19,17 €
83,00 €
Volume
200
Moyenne 50J / 200J
40,52 €
/
49,15 €
Clôture Précédente
22,00 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 6,9 | 0,3 |
| P/B | 0,5 | 2,9 |
| ROE % | 7,4 | 3,7 |
| Net Margin % | 5,4 | 3,8 |
| Rev Growth 5Y % | 9,5 | 10,0 |
| D/E | 0,9 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
4,58 €
4,43 € – 4,71 €
|
2,7 B | 3 |
| FY2029 |
4,75 €
4,59 € – 4,89 €
|
2,7 B | 3 |
| FY2028 |
4,12 €
3,98 € – 4,24 €
|
2,6 B | 4 |
Points Clés
Revenue grew 9,45% annually over 5 years — modest growth
Negative free cash flow of -129,51M
P/E of 6,93 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 7,17%
Croissance
Revenue Growth (5Y)
9,45%
Revenue (1Y)2,28%
Earnings (1Y)-5,52%
FCF Growth (3Y)N/A
Qualité
Return on Equity
7,42%
ROIC5,30%
Net Margin5,39%
Op. Margin9,70%
Sécurité
Debt / Equity
0,85
Current Ratio1,01
Interest Coverage3,26
Valorisation
P/E Ratio
6,93
P/B Ratio0,50
EV/EBITDA9,40
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2,28% | Revenue Growth (3Y) | 5,85% |
| Earnings Growth (1Y) | -5,52% | Earnings Growth (3Y) | 6,84% |
| Revenue Growth (5Y) | 9,45% | Earnings Growth (5Y) | 5,50% |
| Profitability | |||
| Revenue (TTM) | 2,04B | Net Income (TTM) | 109,72M |
| ROE | 7,42% | ROA | 2,88% |
| Gross Margin | 29,85% | Operating Margin | 9,70% |
| Net Margin | 5,39% | Free Cash Flow (TTM) | -129,51M |
| ROIC | 5,30% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,85 | Current Ratio | 1,01 |
| Interest Coverage | 3,26 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 6,93 | P/B Ratio | 0,50 |
| P/S Ratio | 0,37 | PEG Ratio | -2,70 |
| EV/EBITDA | 9,40 | Dividend Yield | 0,02% |
| Market Cap | 759,88M | Enterprise Value | 1,86B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 2,04B | 1,99B | 1,82B | 1,50B | 1,42B |
| Net Income | 109,72M | 116,13M | 96,12M | 83,79M | 88,56M |
| EPS (Diluted) | 3,18 | 3,48 | 3,06 | 2,67 | 2,82 |
| Gross Profit | 607,77M | 597,31M | 546,81M | 442,23M | 437,61M |
| Operating Income | 197,47M | 213,39M | 169,31M | 147,44M | 156,46M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 3,81B | 3,43B | 3,35B | 2,88B | 2,62B |
| Total Liabilities | 2,27B | 1,96B | 2,08B | 1,88B | 1,72B |
| Shareholders' Equity | 1,51B | 1,45B | 1,24B | 981,32M | 883,83M |
| Total Debt | 1,28B | 1,04B | 1,22B | 1,13B | 1,05B |
| Cash & Equivalents | 186,38M | 122,34M | 112,79M | 114,05M | 87,95M |
| Current Assets | 992,30M | 849,57M | 810,14M | 657,18M | 551,37M |
| Current Liabilities | 985,50M | 957,97M | 1,10B | 885,78M | 579,46M |